Biogen Inc
NASDAQ: BIIB
$159.99
-$4.90 (-3.0%)
Closing Price on November 15, 2024
BIIB Articles
ThinkstockShares of Biogen Idec Inc. (NASDAQ: BIIB) did not just do well on Wednesday. The stock hit an all-time high. News hit late in the day that the U.S. Food and Drug Administration has approved...
Published:
Last Updated:
Jon OggIt may be the weekend, and the DJIA hit a new high this last week, but there is no such thing as any rest for the wicked. 24/7 Wall St. has identified 13 must-read weekend stock stories for...
Published:
Last Updated:
Jon Ogg24/7 Wall St. has tracked many stocks on the move in the last week. Now it is the weekend and this can be considered your weekend cheat sheet for the stocks you need to have your eye on come...
Published:
Last Updated:
ThinkstockThe hunt by Big Pharma stocks for smaller drug companies and biotech stocks continues. A report citing “sources” from Dow Jones News has signaled that Bristol-Myers Squibb (NYSE: BMY)...
Published:
Last Updated:
Thinkstock24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector...
Published:
The Fidelity Contrafund has released its 2012 annual report for its shareholders. While the date is December 31, 2012, and the asset size is listed as more than $84 billion as of that date, the...
Published:
Last Updated:
Jon OggThese are some of this Wednesday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX) raised to...
Published:
Last Updated:
U.S. equity markets opened higher this morning boosted by higher-than-expected trade balances in China (more coverage here) and in the U.S. (more coverage here). In Europe the big news came later in...
Published:
Last Updated:
ThinkstockInvesting in biotech or biopharmaceutical stocks can prove to be a very daunting task. Many of the stocks have limited pipelines or their very survival depends on a single binary event that...
Published:
Last Updated:
Jon OggThese are some of this Friday’s top analyst upgrades, downgrades and initiations seen from Wall St. research calls. Alcatel-Lucent S.A. (NYSE: ALU) raised to Overweight at Morgan Stanley and...
Published:
ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) may be a half decade or so late on this move, but as the saying goes “better late than never.” The biotech and drug company is the leader in multiple...
Published:
Last Updated:
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday. Abercrombie & Fitch Co. (NYSE: ANF) raised to Outperform at BMO....
Published:
U.S. equity markets opened mixed this morning on relatively little new data. In Europe, Italian consumer confidence rose more than expected and Germany auctioned 12-month bills at a positive yield...
Published:
Last Updated:
ThinkstockBiogen Idec Inc. (NASDAQ: BIIB) reported fourth-quarter and full-year 2012 results before markets opened this morning. For the quarter, the biotech firm posted adjusted diluted earnings per...
Published:
Last Updated:
U.S. equity markets opened higher this morning before dipping following the report on new home sales in the U.S. Stocks regained positive momentum during most of the remaining session. In Europe,...
Published:
Last Updated: